Urban | Rural | Crude OR | Adj. OR | |||
---|---|---|---|---|---|---|
n | % | n | % | 95% CIb | 95% CIb,c | |
ASTHMA SYMPTOMS | ||||||
Written questionnaire (N = 2340) | ||||||
Wheeze (ever) | 470 | 27.4 | 214 | 34.9 | 0.7 (0.4-1.9) | 0.7 (0.4-1.9) |
Wheeze (12 months prevalence) | 281 | 16.4 | 133 | 21.7 | 0.6 (0.4-1.9) | 0.6 (0.4-1.9) |
Severe asthmaa (12 months prevalence) | 158 | 9.2 | 76 | 12.4 | 0.7 (0.4-1.9) | 0.7 (0.5-1.9) |
Video questionnaire (N = 2300) | ||||||
Wheezing (12 months prevalence) | 124 | 7.3 | 24 | 3.9 | 2.3 (1.1-2.7) | 2.1 (1.0-2.6) |
Exercise-induced wheeze (12 months prevalence) | 323 | 19.2 | 80 | 13.1 | 1.7 (0.9-2.4) | 1.7 (0.9-2.4) |
Dyspnoea at rest (12 months prevalence) | 68 | 4 | 17 | 2.8 | 1.8 (0.7-3.1) | 1.7 (0.7-3.2) |
RHINITIS SYMPTOMS (N = 2327) | ||||||
Rhinitis (ever) | 715 | 41.7 | 255 | 41.6 | 1.0 (0.7-1.6) | 1.0 (0.7-1.6) |
Rhinitis (12 months prevalence) | 490 | 28.6 | 175 | 28.5 | 1.0 (0.7-1.6) | 1.0 (0.8-1.6) |
Rhinoconjunctivitisd (12 months prevalence) | 369 | 21.5 | 147 | 24.0 | 0.8 (0.6-1.8) | 0.8 (0.6-1.8) |
Severe Rhinoconjunctivitise (12 months prevalence) | 43 | 2.5 | 6 | 1.0 | 2.6 (1.1-7.8) | 2.8 (1.2-6.6) |
ECZEMA SYMPTOMS (N = 2303) | ||||||
Itchy rash (ever) | 339 | 20 | 123 | 20.1 | 1.0 (0.7-1.7) | 1.0 (0.7-1.7) |
Itchy rash (12 months prevalence) | 203 | 12.0 | 56 | 9.2 | 1.4 (0.9-1.8) | 1.4 (1.0-1.8) |
Eczemaf (12 months prevalence) | 161 | 9.5 | 52 | 8.5 | 1.1 (0.7-1.8) | 1.2 (0.8-1.8) |
Severe Eczemag (12 months prevalence) | 27 | 1.6 | 3 | 0.5 | 3.3 (1.0-10.9) | 3.3 (1.0-11.0) |